Figure 6.
Kaplan-Meier for ASCVD depending on (a) LDLR, APOB, and PCSK9 mutations and (b) clinical significance of FH-associated variants and time interval for the occurrence of new CV events. Legend: LDLR—low-density cholesterol lipoprotein receptor, APOB—apolipoprotein B, PCSK9—proprotein convertase subtilisin/kexin type 9, CV—cardiovascular.